Coral Laboratories Ltd - Stock Valuation and Financial Performance

BSE: 524506 | NSE: | Pharmaceuticals & Drugs | Small Cap

Coral Laboratories Share Price

733.90 -18.05 -2.40%
as on 20-Dec'24 16:59

DeciZen - make an informed investing decision on Coral Laboratories

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Somewhat overvalued

3. Price Trend

Coral Laboratories stock performance -

mw4me loader
P/E Ratio (SA):
11.34
Market Cap:
262.2 Cr.
52-wk low:
344.9
52-wk high:
999

Is Coral Laboratories Ltd an attractive stock to invest in?

1. Is Coral Laboratories Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Coral Laboratories Ltd is a average quality company.

2. Is Coral Laboratories Ltd undervalued or overvalued?

The key valuation ratios of Coral Laboratories Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

3. Is Coral Laboratories Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Coral Laboratories Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Coral Laboratories:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Coral Laboratories Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 22.2%26.9%27.2%15.9%13.4%7.9%13.4%7.9%5.4%12.5%-
Value Creation
Index
0.60.91.00.10.0-0.4-0.1-0.4-0.6-0.1-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 59.47795.592.591.170.696.675.678.183.7111
Sales YoY Gr.-29.6%24%-3.1%-1.5%-22.5%36.8%-21.7%3.3%7.1%-
Adj EPS 25.232.946.232.625.416.637.922.611.642.764.7
YoY Gr.-30.2%40.5%-29.3%-22.1%-34.8%128.6%-40.4%-48.6%266.7%-
BVPS (₹) 165.4196.4305.5325.6318.5323.8382.5436.8433.3496.8569.8
Adj Net
Profit
911.716.511.79.15.913.68.14.215.223
Cash Flow from Ops. 0.45.110.813.5-0.9-3.90.96.112.7-5.5-
Debt/CF from Ops. 3.70.10.20.1-1.6-1.56.7100-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 3.9%-1.7%-4.7%7.1%
Adj EPS 6%10.9%4%266.7%
BVPS13%9.3%9.1%14.7%
Share Price 15.8% 39.5% 36% 70.7%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
16.518.218.410.37.95.210.75.52.79.212.1
Op. Profit
Mgn %
20.821.424.416.613.67.716.410.94.919.423.1
Net Profit
Mgn %
15.215.217.312.6108.41410.75.318.220.9
Debt to
Equity
000000.10.10000
Working Cap
Days
235241229243247332273382346301238
Cash Conv.
Cycle
130127127140129181146213180120201

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 12.10%

Sales growth is good in last 4 quarters at 74.63%

Sales growth has been subdued in last 3 years -4.67%

Net Profit has been subdued in last 3 years 3.98%

Latest Financials - Coral Laboratories Ltd.

Standalone Consolidated
TTM EPS (₹) 64.7 -
TTM Sales (₹ Cr.) 111 -
BVPS (₹.) 569.8 -
Reserves (₹ Cr.) 189 -
P/BV 1.29 -
PE 11.34 -
From the Market
52 Week Low / High (₹) 344.90 / 999.00
All Time Low / High (₹) 7.25 / 1190.00
Market Cap (₹ Cr.) 262
Equity (₹ Cr.) 3.6
Face Value (₹) 10
Industry PE 44.3

Management X-Ray of Coral Laboratories:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Coral Laboratories

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales59779592917197767884
Operating Expenses 47617277796581677467
Manufacturing Costs18223225281926212223
Material Costs21272936322732263122
Employee Cost 4579101010111111
Other Costs 47589913101012
Operating Profit 12162315125168416
Operating Profit Margin (%) 20.8%21.4%24.4%16.6%13.6%7.7%16.4%10.9%4.9%19.4%
Other Income 3334564577
Interest 0000000000
Depreciation 3222222222
Exceptional Items 0000000100
Profit Before Tax 121725181691812821
Tax 3586524325
Profit After Tax 10121612107149616
PAT Margin (%) 16.1%16.1%17.1%13.5%11.2%10.1%14.0%12.0%8.3%18.9%
Adjusted EPS (₹)26.834.745.634.828.620.037.925.318.044.2
Dividend Payout Ratio (%)9%9%11%6%7%0%0%0%0%5%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 5970109116114116137156155177
Share Capital 4444444444
Reserves 5567106113110112133152151174
Minority Interest0000000000
Debt1022166600
Long Term Debt0000000000
Short Term Debt1022166600
Trade Payables61010131314159413
Others Liabilities 691098910191515
Total Liabilities 7289131140136144168190174206

Fixed Assets

Gross Block33343237394041464950
Accumulated Depreciation14161415171921232527
Net Fixed Assets19181821222220232423
CWIP 0000001200
Investments 153946292633464150
Inventories10132118161922181315
Trade Receivables25283132303439382328
Cash Equivalents 791211233035374061
Others Assets10171012151318253228
Total Assets 7289131140136144168190174206

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 051113-1-41613-5
PBT 121725181691811821
Adjustment 100111000-2
Changes in Working Capital -10-6-50-13-13-13-06-20
Tax Paid -2-5-9-6-5-1-3-4-2-5
Cash Flow From Investing Activity 0-3-10-133-20-6-31
Capex -2-1-2-5-3-1-1-6-2-1
Net Investments 0-3-9-9500-2-20
Others 1211101212
Cash Flow From Financing Activity 000-3-1400-60
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid 0000000000
Dividend Paid 00-1-2-1-10000
Others 00200400-60
Net Cash Flow 021-21-2104-4
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)17.4619.1818.1711.048.886.2210.746.184.159.5
ROCE (%)22.2226.9327.2315.9113.447.8613.357.875.4112.48
Asset Turnover Ratio0.920.970.870.680.660.50.620.420.430.44
PAT to CFO Conversion(x)00.420.691.08-0.1-0.570.070.672.17-0.31
Working Capital Days
Receivable Days119122112123124167139187144113
Inventory Days56556576689277977260
Payable Days10110712611614418116516776147

Coral Laboratories Ltd Stock News

Coral Laboratories Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Coral Laboratories on 20-Dec-2024 16:59 is ₹733.9.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 20-Dec-2024 16:59 the market cap of Coral Laboratories stood at ₹262.2.
The latest P/E ratio of Coral Laboratories as of 20-Dec-2024 16:59 is 11.34.
The latest P/B ratio of Coral Laboratories as of 20-Dec-2024 16:59 is 1.29.
The 52-week high of Coral Laboratories is ₹999.0 and the 52-week low is ₹344.9.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Coral Laboratories is ₹110.8 ( Cr.) .

About Coral Laboratories Ltd

Coral Laboratories was founded in 1994. The company is equipped with an ultra modern manufacturing unit in the state of Gujarat, Daman & today is a force to reckon with in the pharmaceutical industry; a fact which has been endorsed by the WHO GMP certification issued by the Food & Drugs Control Administration and ISO 9001-2000 Quality certification issued by American Quality Assessors.

The Company with deep basket of products is focused in hostlic human welfare and is bringing planfort to people with its Inflammatory, Bacterial, Biotic, Protein deficiencies & Skin conditions. Medicines across the nation, manufactured under the ZEST group & MOXBRO group being the most popular brands across the nation, manufactured by the company.Coral Laboratories has been following a steady growth path on the pillars of its philosophy of “Total Quality Management” & “Quality Products at Affordable Prices”.

The state-of-the art manufacturing facilities meet the stringent and over changing quality requirement of the most discerning buyers. Coral has a multi location manufacturing facilities based on Baroda, Daman & Vasai for strategies convenience. The facilities carrying WHO-GMP & ISO 9001 : 2000 certification. The new manufacturing facilities under expansion to have UK – MHRA and US– FDA certification.

Coral has one of the best quality control laboratory in indian pharmaceuticals industry equipped with latest and sensitive laboratory instruments.

Product range of the company includes:

  • Capsules & Dry Syrups
  • Tablets
  • Liquid Orals
  • Kits
  • Ointment & Cream
  • Injection – Eye – Ear Drops
  • Others

Achievements/ recognition:

  • WHO GMP certification issued by the Food & Drugs Control Administration
  • ISO 9001-2000 Quality certification issued by American Quality Assessors.
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.